Jeff Johnson
Stock Analyst at Robert W. Baird
(4.52)
# 1,062
Out of 4,639 analysts
615
Total ratings
51.4%
Success rate
10.5%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintained: Hold | $14 → $15 | $11.61 | +29.20% | 54 | Aug 7, 2026 | |
| PODD Insulet | Maintained: Buy | $248 → $175 | $144.70 | +20.94% | 46 | Aug 6, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $92 → $104 | $97.23 | +6.96% | 38 | Aug 6, 2026 | |
| NVST Envista Holdings | Maintained: Buy | $31 → $34 | $28.52 | +19.21% | 38 | Aug 6, 2026 | |
| HSIC Henry Schein | Maintained: Buy | $97 → $109 | $89.18 | +22.22% | 57 | Aug 5, 2026 | |
| DXCM DexCom | Maintained: Buy | $80 → $105 | $89.53 | +17.28% | 61 | Jul 31, 2026 | |
| INMD InMode | Maintained: Hold | $14 → $17 | $15.14 | +12.29% | 39 | Jul 14, 2026 | |
| COO The Cooper Companies | Maintained: Buy | $98 → $85 | $76.82 | +10.65% | 55 | Jun 5, 2026 | |
| ENOV Enovis | Maintained: Buy | $45 → $37 | $24.60 | +50.41% | 15 | May 8, 2026 | |
| SWX: ALC Alcon Inc. | Maintained: Buy | CHF 76.83 → CHF 72.79 | CHF 61.06 | +19.21% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $437 → $385 | $348.15 | +10.58% | 37 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $28 → $14 | $17.62 | -20.54% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $205 → $218 | $172.96 | +26.04% | 66 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $18 → $30 | $23.44 | +27.99% | 60 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $51.19 | n/a | 1 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $67 | $4.83 | n/a | 1 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $42 → $49 | - | n/a | 6 | Dec 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $100.68 | n/a | 1 | Apr 11, 2016 |
DENTSPLY SIRONA
Aug 7, 2026
Maintained: Hold
Price Target: $14 → $15
Current: $11.61
Upside: +29.20%
Insulet
Aug 6, 2026
Maintained: Buy
Price Target: $248 → $175
Current: $144.70
Upside: +20.94%
Zimmer Biomet Holdings
Aug 6, 2026
Maintained: Hold
Price Target: $92 → $104
Current: $97.23
Upside: +6.96%
Envista Holdings
Aug 6, 2026
Maintained: Buy
Price Target: $31 → $34
Current: $28.52
Upside: +19.21%
Henry Schein
Aug 5, 2026
Maintained: Buy
Price Target: $97 → $109
Current: $89.18
Upside: +22.22%
DexCom
Jul 31, 2026
Maintained: Buy
Price Target: $80 → $105
Current: $89.53
Upside: +17.28%
InMode
Jul 14, 2026
Maintained: Hold
Price Target: $14 → $17
Current: $15.14
Upside: +12.29%
The Cooper Companies
Jun 5, 2026
Maintained: Buy
Price Target: $98 → $85
Current: $76.82
Upside: +10.65%
Enovis
May 8, 2026
Maintained: Buy
Price Target: $45 → $37
Current: $24.60
Upside: +50.41%
Alcon Inc.
May 7, 2026
Maintained: Buy
Price Target: CHF 76.83 → CHF 72.79
Current: CHF 61.06
Upside: +19.21%
May 1, 2026
Maintained: Buy
Price Target: $437 → $385
Current: $348.15
Upside: +10.58%
Feb 18, 2026
Maintained: Hold
Price Target: $28 → $14
Current: $17.62
Upside: -20.54%
Feb 5, 2026
Maintained: Buy
Price Target: $205 → $218
Current: $172.96
Upside: +26.04%
Dec 16, 2025
Upgraded: Buy
Price Target: $18 → $30
Current: $23.44
Upside: +27.99%
Dec 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $51.19
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $67
Current: $4.83
Upside: n/a
Dec 4, 2017
Reiterated: Hold
Price Target: $42 → $49
Current: -
Upside: n/a
Apr 11, 2016
Reiterated: Hold
Price Target: n/a
Current: $100.68
Upside: n/a